Inventor
KANATANI AKIO
JP46 patents
⚠️ This page may combine multiple inventors who share the name “KANATANI AKIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BANYU PHARMA CO LTD
40 patentsUS6335345B1Jan 1, 2002
Spiro compounds
BANYU PHARMA CO LTD120 citations99
US6326375B1Dec 4, 2001
Spiro compounds
BANYU PHARMA CO LTD148 citations99
US7521455B2Apr 21, 2009
Fused ring 4-oxopyrimidine derivative
BANYU PHARMA CO LTD46 citations95
US7064142B2Jun 20, 2006
Imidazonline compounds
BANYU PHARMA CO LTD54 citations95
US6258837B1Jul 10, 2001
Neuropeptide Y receptor antagonist
BANYU PHARMA CO LTD75 citations95
US6803372B2Oct 12, 2004
Spiro compounds
BANYU PHARMA CO LTD23 citations92
US6723847B2Apr 20, 2004
Spiro compounds
BANYU PHARMA CO LTD17 citations92
US6649624B2Nov 18, 2003
Spiro compounds
BANYU PHARMA CO LTD27 citations92
US6462053B1Oct 8, 2002
Spiro compounds
BANYU PHARMA CO LTD21 citations92
US6388077B1May 14, 2002
Spiro compounds
BANYU PHARMA CO LTD28 citations92
US6166038ADec 26, 2000
Aminopyrazole derivatives
BANYU PHARMA CO LTD27 citations92
US6057335AMay 2, 2000
Pyrazole derivatives
BANYU PHARMA CO LTD29 citations92
US6043246AMar 28, 2000
Urea derivatives
BANYU PHARMA CO LTD41 citations92
US7595316B2Sep 29, 2009
Heteroaryloxy nitrogenous saturated heterocyclic derivative
BANYU PHARMA CO LTD18 citations90
US7727998B2Jun 1, 2010
Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
BANYU PHARMA CO LTD17 citations84
US7691860B2Apr 6, 2010
Sulfonamide derivatives
BANYU PHARMA CO LTD9 citations84
US7365079B2Apr 29, 2008
Azole derivatives
BANYU PHARMA CO LTD11 citations83
US7547693B2Jun 16, 2009
Piperidine derivative
BANYU PHARMA CO LTD14 citations82
US7504412B2Mar 17, 2009
Imidazopyridine derivatives
BANYU PHARMA CO LTD10 citations82
US6180653B1Jan 30, 2001
Aminopyrazole derivatives
BANYU PHARMA CO LTD13 citations73
US7105526B2Sep 12, 2006
Benzimidazole derivatives
BANYU PHARMA CO LTD6 citations72
US7790731B2Sep 7, 2010
Crystal form of 2-methyl-3-{4-[3-(1-pyrrolidinyl)propoxy]phenyl}-5-trifluoromethyl-4(3H)-quinazolinone
BANYU PHARMA CO LTD2 citations62
US7732456B2Jun 8, 2010
Pyridone derivative
BANYU PHARMA CO LTD3 citations62
US7589096B2Sep 15, 2009
Azole derivatives
BANYU PHARMA CO LTD2 citations62
US7541477B2Jun 2, 2009
Antagonists to melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient
BANYU PHARMA CO LTD3 citations61
US7485647B2Feb 3, 2009
2-aminoquinoline derivatives
BANYU PHARMA CO LTD2 citations61
US7304072B2Dec 4, 2007
Spiro compounds
BANYU PHARMA CO LTD2 citations61
US6869966B2Mar 22, 2005
N-substituted-2-oxodihydropyridine derivatives
BANYU PHARMA CO LTD3 citations61
US7566781B2Jul 28, 2009
Imidazopyridine compound
BANYU PHARMA CO LTD7 citations59
US6011039AJan 4, 2000
Aminopyridine derivatives
BANYU PHARMA CO LTD1 citations52
US7834182B2Nov 16, 2010
Piperidine derivative
BANYU PHARMA CO LTD0 citations51
US7803807B2Sep 28, 2010
Benzimidazole derivatives
BANYU PHARMA CO LTD1 citations51
US7687514B2Mar 30, 2010
Benzimidazole derivatives
BANYU PHARMA CO LTD1 citations51
US7482358B2Jan 27, 2009
Imidazoline compounds
BANYU PHARMA CO LTD0 citations51
US7138525B2Nov 21, 2006
N-substituted-2-oxodihydropyridine derivatives
BANYU PHARMA CO LTD1 citations51
US7119107B2Oct 10, 2006
Pyridone derivatives
BANYU PHARMA CO LTD0 citations51
US7531668B2May 12, 2009
2-arylcarboxamide-nitrogenous heterocycle compound
BANYU PHARMA CO LTD1 citations50
US7510833B2Mar 31, 2009
Method for examining obesity or leanness
BANYU PHARMA CO LTD0 citations49
US7960394B2Jun 14, 2011
Quinazoline derivative
BANYU PHARMA CO LTD0 citations41
US7645756B2Jan 12, 2010
Nitrogenous fused heteroaromatic ring derivative
BANYU PHARMA CO LTD0 citations41
MERCK & CO INC
4 patentsUS6313298B1Nov 6, 2001
Spiro-indolines as Y5 receptor antagonists
MERCK & CO INC79 citations96
US6191160B1Feb 20, 2001
Spiro-indolines as Y5 receptor antagonists
MERCK & CO INC79 citations96
US6638942B1Oct 28, 2003
Spiro-indolines as Y5 receptor antagonists
MERCK & CO INC10 citations73
US6495559B2Dec 17, 2002
NPY Y5 receptor antagonists
MERCK & CO INC5 citations73